We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
236 hedge funds and large institutions have $3B invested in Array Biopharma Inc in 2018 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more call options, than puts
Call options by funds: $31.1M | Put options by funds: $12.4M
111% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 27
13% more funds holding
Funds holding: 208 → 236 (+28)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
0% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 74
4% less capital invested
Capital invested by funds: $3.11B → $3B (-$111M)
Holders
236
Holders Change
+28
Holders Change %
+13.46%
% of All Funds
5.26%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.2%
New
57
Increased
74
Reduced
74
Closed
27
Calls
$31.1M
Puts
$12.4M
Net Calls
+$18.7M
Net Calls Change
+$10.1M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$99.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$69.7M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$28.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$23.1M |
| 5 |
Goldman Sachs
New York
|
+$21.1M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$73.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$25.4M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$23.5M |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$11.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.2M |
